Biogen Inc. buy Needham & Company LLC
Start price
26.10.23
/
50%
€229.60
Target price
26.10.24
€289.60
Performance (%)
-26.20%
End price
27.10.24
€169.45
Summary
This prediction ended on 27.10.24 with a price of €169.45. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.20%. Needham___Company_LL has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 3.151% | 3.151% | 67.323% |
| iShares Core DAX® | -1.111% | -0.848% | 2.018% |
| iShares Nasdaq 100 | -4.346% | -5.765% | 26.249% |
| iShares Nikkei 225® | -6.785% | -10.345% | 53.208% |
| iShares S&P 500 | -1.788% | -0.332% | 21.463% |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $305.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten